Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 74 entries
Sorted by: Best Match Show Resources per page
Diversity and host preference of leaf endophytic fungi in the Iwokrama Forest Reserve, Guyana.

Mycologia

Cannon PF, Simmons CM.
PMID: 21156490
Mycologia. 2002 Mar-Apr;94(2):210-20.

Endophytic fungi were isolated from living symptomless leaves of 12 tree species from two locations in the Iwokrama Forest Reserve, Guyana. Sixty-four fungal morphotaxa were characterized from 2492 cultures, which were derived from a total of 2520 sample units....

Cite
Cannon PF, Simmons CM. Diversity and host preference of leaf endophytic fungi in the Iwokrama Forest Reserve, Guyana. Mycologia. 2002;94(2):210-20
Cannon, P. F., & Simmons, C. M. (2002). Diversity and host preference of leaf endophytic fungi in the Iwokrama Forest Reserve, Guyana. Mycologia, 94(2), 210-20.
Cannon, Paul F, and Simmons, Coralie M. "Diversity and host preference of leaf endophytic fungi in the Iwokrama Forest Reserve, Guyana." Mycologia vol. 94,2 (2002): 210-20.
Cannon PF, Simmons CM. Diversity and host preference of leaf endophytic fungi in the Iwokrama Forest Reserve, Guyana. Mycologia. 2002 Mar-Apr;94(2):210-20. PMID: 21156490.
Copy Download .nbib Format: NLM
Effect of isomerism and chain length on electronic structure, photophysics, and sensitizer efficiency in quadrupolar (donor)₂-acceptor systems for application in dye-sensitized solar cells.

ACS applied materials & interfaces

Richard CA, Pan Z, Hsu HY, Cekli S, Schanze KS, Reynolds JR.
PMID: 24666032
ACS Appl Mater Interfaces. 2014 Apr 09;6(7):5221-7. doi: 10.1021/am500535k. Epub 2014 Mar 25.

We report on quadrupolar (donor)2-acceptor sensitizers for dye-sensitized solar cells (DSSCs). The acceptor units are based on dithieno[2,3-a:3',2'-c]phenazine and dithieno[3,2-a:2',3'-c]phenazine coupled to thiophene donors. The optoelectronic and photophysical properties of two sets of isomers reveal a rigid structure for...

Cite
Richard CA, Pan Z, Hsu HY, et al. Effect of isomerism and chain length on electronic structure, photophysics, and sensitizer efficiency in quadrupolar (donor)₂-acceptor systems for application in dye-sensitized solar cells. ACS Appl Mater Interfaces. 2014;6(7):5221-7doi: 10.1021/am500535k.
Richard, C. A., Pan, Z., Hsu, H. Y., Cekli, S., Schanze, K. S., & Reynolds, J. R. (2014). Effect of isomerism and chain length on electronic structure, photophysics, and sensitizer efficiency in quadrupolar (donor)₂-acceptor systems for application in dye-sensitized solar cells. ACS applied materials & interfaces, 6(7), 5221-7. https://doi.org/10.1021/am500535k
Richard, Coralie A, et al. "Effect of isomerism and chain length on electronic structure, photophysics, and sensitizer efficiency in quadrupolar (donor)₂-acceptor systems for application in dye-sensitized solar cells." ACS applied materials & interfaces vol. 6,7 (2014): 5221-7. doi: https://doi.org/10.1021/am500535k
Richard CA, Pan Z, Hsu HY, Cekli S, Schanze KS, Reynolds JR. Effect of isomerism and chain length on electronic structure, photophysics, and sensitizer efficiency in quadrupolar (donor)₂-acceptor systems for application in dye-sensitized solar cells. ACS Appl Mater Interfaces. 2014 Apr 09;6(7):5221-7. doi: 10.1021/am500535k. Epub 2014 Mar 25. PMID: 24666032.
Copy Download .nbib Format: NLM
Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department.

The Annals of pharmacotherapy

Lee A, Coralic Z.
PMID: 33998315
Ann Pharmacother. 2022 Feb;56(2):151-154. doi: 10.1177/10600280211018516. Epub 2021 May 17.

BACKGROUND: Cannabinoid hyperemesis syndrome (CHS) is characterized by cyclical nausea, vomiting, and abdominal pain often relieved with hot showers. Patients with CHS are usually long-term cannabis smokers whose symptoms are not relieved by antiemetics. The use of topical capsaicin...

Cite
Lee A, Coralic Z. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department. Ann Pharmacother. 2021;56(2):151-154doi: 10.1177/10600280211018516.
Lee, A., & Coralic, Z. (2022). Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department. The Annals of pharmacotherapy, 56(2), 151-154. https://doi.org/10.1177/10600280211018516
Lee, Allison, and Coralic, Zlatan. "Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department." The Annals of pharmacotherapy vol. 56,2 (2022): 151-154. doi: https://doi.org/10.1177/10600280211018516
Lee A, Coralic Z. Use of Capsaicin Cream in Cannabinoid Hyperemesis Syndrome in Patients Presenting to the Emergency Department. Ann Pharmacother. 2022 Feb;56(2):151-154. doi: 10.1177/10600280211018516. Epub 2021 May 17. PMID: 33998315.
Copy Download .nbib Format: NLM
Epilepsy and Malaria in Children Aged 1 to 15 Years in Parakou in 2018: Case-Control Study.

Child neurology open

Thierry A, Falilatou A, Covalic B, Elodie D, Mendinatou A, Didier A, Alphonse N, Joseph A.
PMID: 33117857
Child Neurol Open. 2020 Oct 14;7:2329048X20954111. doi: 10.1177/2329048X20954111. eCollection 2020.

OBJECTIVE: To study the link between malaria and epilepsy in children in Parakou district.METHODS: This case-control study included children 1-15 years of age with epilepsy. Each case of epilepsy was matched to 2 controls for age, sex and neighborhood...

Cite
Thierry A, Falilatou A, Covalic B, et al. Epilepsy and Malaria in Children Aged 1 to 15 Years in Parakou in 2018: Case-Control Study. Child Neurol Open. 2020;7:2329048X20954111doi: 10.1177/2329048X20954111.
Thierry, A., Falilatou, A., Covalic, B., Elodie, D., Mendinatou, A., Didier, A., Alphonse, N., & Joseph, A. (2020). Epilepsy and Malaria in Children Aged 1 to 15 Years in Parakou in 2018: Case-Control Study. Child neurology open, 72329048X20954111. https://doi.org/10.1177/2329048X20954111
Thierry, Adoukonou, et al. "Epilepsy and Malaria in Children Aged 1 to 15 Years in Parakou in 2018: Case-Control Study." Child neurology open vol. 7 (2020): 2329048X20954111. doi: https://doi.org/10.1177/2329048X20954111
Thierry A, Falilatou A, Covalic B, Elodie D, Mendinatou A, Didier A, Alphonse N, Joseph A. Epilepsy and Malaria in Children Aged 1 to 15 Years in Parakou in 2018: Case-Control Study. Child Neurol Open. 2020 Oct 14;7:2329048X20954111. doi: 10.1177/2329048X20954111. eCollection 2020. PMID: 33117857; PMCID: PMC7573707.
Copy Download .nbib Format: NLM
Current concepts on endothelial stem cells definition, location, and markers.

Stem cells translational medicine

Chambers SEJ, Pathak V, Pedrini E, Soret L, Gendron N, Guerin CL, Stitt AW, Smadja DM, Medina RJ.
PMID: 34724714
Stem Cells Transl Med. 2021 Nov;10:S54-S61. doi: 10.1002/sctm.21-0022.

Ischemic vascular disease is a major cause of mortality and morbidity worldwide, and regeneration of blood vessels in perfusion-deficient tissues is a worthwhile therapeutic goal. The idea of delivering endothelial stem/progenitor cells to repair damaged vasculature, reperfuse hypoxic tissue,...

Cite
Chambers SEJ, Pathak V, Pedrini E, et al. Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl Med. 2021;10:S54-S61doi: 10.1002/sctm.21-0022.
Chambers, S. E. J., Pathak, V., Pedrini, E., Soret, L., Gendron, N., Guerin, C. L., Stitt, A. W., Smadja, D. M., & Medina, R. J. (2021). Current concepts on endothelial stem cells definition, location, and markers. Stem cells translational medicine, 10S54-S61. https://doi.org/10.1002/sctm.21-0022
Chambers, Sarah E J, et al. "Current concepts on endothelial stem cells definition, location, and markers." Stem cells translational medicine vol. 10 (2021): S54-S61. doi: https://doi.org/10.1002/sctm.21-0022
Chambers SEJ, Pathak V, Pedrini E, Soret L, Gendron N, Guerin CL, Stitt AW, Smadja DM, Medina RJ. Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl Med. 2021 Nov;10:S54-S61. doi: 10.1002/sctm.21-0022. PMID: 34724714; PMCID: PMC8560200.
Copy Download .nbib Format: NLM
Platelet activation in critically ill COVID-19 patients.

Annals of intensive care

Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B.
PMID: 34273008
Ann Intensive Care. 2021 Jul 17;11(1):113. doi: 10.1186/s13613-021-00899-1.

BACKGROUND: Microvascular, arterial and venous thrombotic events have been largely described during severe coronavirus disease 19 (COVID-19). However, mechanisms underlying hemostasis dysregulation remain unclear.METHODS: We explored two independent cross-sectional cohorts to identify soluble markers and gene-expression signatures that discriminated...

Cite
Yatim N, Boussier J, Chocron R, et al. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care. 2021;11(1):113doi: 10.1186/s13613-021-00899-1.
Yatim, N., Boussier, J., Chocron, R., Hadjadj, J., Philippe, A., Gendron, N., Barnabei, L., Charbit, B., Szwebel, T. A., Carlier, N., Pène, F., Azoulay, C., Khider, L., Mirault, T., Diehl, J. L., Guerin, C. L., Rieux-Laucat, F., Duffy, D., Kernéis, S., Smadja, D. M., & Terrier, B. (2021). Platelet activation in critically ill COVID-19 patients. Annals of intensive care, 11(1), 113. https://doi.org/10.1186/s13613-021-00899-1
Yatim, Nader, et al. "Platelet activation in critically ill COVID-19 patients." Annals of intensive care vol. 11,1 (2021): 113. doi: https://doi.org/10.1186/s13613-021-00899-1
Yatim N, Boussier J, Chocron R, Hadjadj J, Philippe A, Gendron N, Barnabei L, Charbit B, Szwebel TA, Carlier N, Pène F, Azoulay C, Khider L, Mirault T, Diehl JL, Guerin CL, Rieux-Laucat F, Duffy D, Kernéis S, Smadja DM, Terrier B. Platelet activation in critically ill COVID-19 patients. Ann Intensive Care. 2021 Jul 17;11(1):113. doi: 10.1186/s13613-021-00899-1. PMID: 34273008; PMCID: PMC8286043.
Copy Download .nbib Format: NLM
Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam.

Journal of controlled release : official journal of the Controlled Release Society

Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, Park K, Yeo Y.
PMID: 34990702
J Control Release. 2022 Jan 03;342:189-200. doi: 10.1016/j.jconrel.2021.12.038. Epub 2022 Jan 03.

For effective resolution of regional subacute inflammation and prevention of biofouling formation, we have developed a polymeric implant that can release meloxicam, a selective cyclooxygenase (COX)-2 inhibitor, in a sustained manner. Meloxicam-loaded polymer matrices were produced by hot-melt extrusion,...

Cite
Chen YC, Moseson DE, Richard CA, et al. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J Control Release. 2022;342:189-200doi: 10.1016/j.jconrel.2021.12.038.
Chen, Y. C., Moseson, D. E., Richard, C. A., Swinney, M. R., Horava, S. D., Oucherif, K. A., Cox, A. L., Hawkins, E. D., Li, Y., DeNeve, D. F., Lomeo, J., Zhu, A., Lyle, L. T., Munson, E. J., Taylor, L. S., Park, K., & Yeo, Y. (2022). Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. Journal of controlled release : official journal of the Controlled Release Society, 342189-200. https://doi.org/10.1016/j.jconrel.2021.12.038
Chen, Yun-Chu, et al. "Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam." Journal of controlled release : official journal of the Controlled Release Society vol. 342 (2022): 189-200. doi: https://doi.org/10.1016/j.jconrel.2021.12.038
Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, Park K, Yeo Y. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J Control Release. 2022 Jan 03;342:189-200. doi: 10.1016/j.jconrel.2021.12.038. Epub 2022 Jan 03. PMID: 34990702.
Copy Download .nbib Format: NLM
Current concepts on endothelial stem cells definition, location, and markers.

Stem cells translational medicine

Chambers SEJ, Pathak V, Pedrini E, Soret L, Gendron N, Guerin CL, Stitt AW, Smadja DM, Medina RJ.
PMID: 34724714
Stem Cells Transl Med. 2021 Nov;10:S54-S61. doi: 10.1002/sctm.21-0022.

Ischemic vascular disease is a major cause of mortality and morbidity worldwide, and regeneration of blood vessels in perfusion-deficient tissues is a worthwhile therapeutic goal. The idea of delivering endothelial stem/progenitor cells to repair damaged vasculature, reperfuse hypoxic tissue,...

Cite
Chambers SEJ, Pathak V, Pedrini E, et al. Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl Med. 2021;10:S54-S61doi: 10.1002/sctm.21-0022.
Chambers, S. E. J., Pathak, V., Pedrini, E., Soret, L., Gendron, N., Guerin, C. L., Stitt, A. W., Smadja, D. M., & Medina, R. J. (2021). Current concepts on endothelial stem cells definition, location, and markers. Stem cells translational medicine, 10S54-S61. https://doi.org/10.1002/sctm.21-0022
Chambers, Sarah E J, et al. "Current concepts on endothelial stem cells definition, location, and markers." Stem cells translational medicine vol. 10 (2021): S54-S61. doi: https://doi.org/10.1002/sctm.21-0022
Chambers SEJ, Pathak V, Pedrini E, Soret L, Gendron N, Guerin CL, Stitt AW, Smadja DM, Medina RJ. Current concepts on endothelial stem cells definition, location, and markers. Stem Cells Transl Med. 2021 Nov;10:S54-S61. doi: 10.1002/sctm.21-0022. PMID: 34724714; PMCID: PMC8560200.
Copy Download .nbib Format: NLM
Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells.

Journal of thrombosis and haemostasis : JTH

Détriché G, Gendron N, Philippe A, Gruest M, Billoir P, Rossi E, Guerin CL, Lokajczyk A, Brabant S, Prié D, Mirault T, Smadja DM.
PMID: 34623025
J Thromb Haemost. 2021 Oct 08; doi: 10.1111/jth.15549. Epub 2021 Oct 08.

BACKGROUND: The impact of estrogen and testosterone on atherosclerotic cardiovascular disease is well known, but the role of the gonadotropins follicle-stimulating hormone (FSH), luteinizing hormone (LH), and prolactin (PRL) to some extent remain less studied.OBJECTIVES: To explore the angiogenic...

Cite
Détriché G, Gendron N, Philippe A, et al. Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells. J Thromb Haemost. 2021;doi: 10.1111/jth.15549.
Détriché, G., Gendron, N., Philippe, A., Gruest, M., Billoir, P., Rossi, E., Guerin, C. L., Lokajczyk, A., Brabant, S., Prié, D., Mirault, T., & Smadja, D. M. (2021). Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells. Journal of thrombosis and haemostasis : JTH, . https://doi.org/10.1111/jth.15549
Détriché, Grégoire, et al. "Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells." Journal of thrombosis and haemostasis : JTH vol. (2021). doi: https://doi.org/10.1111/jth.15549
Détriché G, Gendron N, Philippe A, Gruest M, Billoir P, Rossi E, Guerin CL, Lokajczyk A, Brabant S, Prié D, Mirault T, Smadja DM. Gonadotropins as novel active partners in vascular diseases: Insight from angiogenic properties and thrombotic potential of endothelial colony-forming cells. J Thromb Haemost. 2021 Oct 08; doi: 10.1111/jth.15549. Epub 2021 Oct 08. PMID: 34623025.
Copy Download .nbib Format: NLM
Magnetic resonance enterography: the test of choice in diagnosing intestinal "zebras".

Case reports in gastrointestinal medicine

Kumar AS, Coralic J, Vegeler R, Kolli K, Liang J, Estep A, Chudzinski AP, McFadden JD.
PMID: 25692051
Case Rep Gastrointest Med. 2015;2015:206469. doi: 10.1155/2015/206469. Epub 2015 Jan 26.

Small bowel tumors and other rare intestinal disorders are often exceedingly difficult to identify. Even cutting-edge technologies, such as push enteroscopy and capsule endoscopy, can fail to determine the cause of a patient's symptoms. At our institution magnetic resonance...

Cite
Kumar AS, Coralic J, Vegeler R, et al. Magnetic resonance enterography: the test of choice in diagnosing intestinal "zebras". Case Rep Gastrointest Med. 2015;2015:206469doi: 10.1155/2015/206469.
Kumar, A. S., Coralic, J., Vegeler, R., Kolli, K., Liang, J., Estep, A., Chudzinski, A. P., & McFadden, J. D. (2015). Magnetic resonance enterography: the test of choice in diagnosing intestinal "zebras". Case reports in gastrointestinal medicine, 2015206469. https://doi.org/10.1155/2015/206469
Kumar, Anjali S, et al. "Magnetic resonance enterography: the test of choice in diagnosing intestinal "zebras"." Case reports in gastrointestinal medicine vol. 2015 (2015): 206469. doi: https://doi.org/10.1155/2015/206469
Kumar AS, Coralic J, Vegeler R, Kolli K, Liang J, Estep A, Chudzinski AP, McFadden JD. Magnetic resonance enterography: the test of choice in diagnosing intestinal "zebras". Case Rep Gastrointest Med. 2015;2015:206469. doi: 10.1155/2015/206469. Epub 2015 Jan 26. PMID: 25692051; PMCID: PMC4321082.
Copy Download .nbib Format: NLM
Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam.

Journal of controlled release : official journal of the Controlled Release Society

Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, Park K, Yeo Y.
PMID: 34990702
J Control Release. 2022 Jan 03;342:189-200. doi: 10.1016/j.jconrel.2021.12.038. Epub 2022 Jan 03.

For effective resolution of regional subacute inflammation and prevention of biofouling formation, we have developed a polymeric implant that can release meloxicam, a selective cyclooxygenase (COX)-2 inhibitor, in a sustained manner. Meloxicam-loaded polymer matrices were produced by hot-melt extrusion,...

Cite
Chen YC, Moseson DE, Richard CA, et al. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J Control Release. 2022;342:189-200doi: 10.1016/j.jconrel.2021.12.038.
Chen, Y. C., Moseson, D. E., Richard, C. A., Swinney, M. R., Horava, S. D., Oucherif, K. A., Cox, A. L., Hawkins, E. D., Li, Y., DeNeve, D. F., Lomeo, J., Zhu, A., Lyle, L. T., Munson, E. J., Taylor, L. S., Park, K., & Yeo, Y. (2022). Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. Journal of controlled release : official journal of the Controlled Release Society, 342189-200. https://doi.org/10.1016/j.jconrel.2021.12.038
Chen, Yun-Chu, et al. "Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam." Journal of controlled release : official journal of the Controlled Release Society vol. 342 (2022): 189-200. doi: https://doi.org/10.1016/j.jconrel.2021.12.038
Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, Park K, Yeo Y. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J Control Release. 2022 Jan 03;342:189-200. doi: 10.1016/j.jconrel.2021.12.038. Epub 2022 Jan 03. PMID: 34990702.
Copy Download .nbib Format: NLM
Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam.

Journal of controlled release : official journal of the Controlled Release Society

Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, Park K, Yeo Y.
PMID: 34990702
J Control Release. 2022 Jan 03; doi: 10.1016/j.jconrel.2021.12.038. Epub 2022 Jan 03.

For effective resolution of regional subacute inflammation and prevention of biofouling formation, we have developed a polymeric implant that can release meloxicam, a selective cyclooxygenase (COX)-2 inhibitor, in a sustained manner. Meloxicam-loaded polymer matrices were produced by hot-melt extrusion,...

Cite
Chen YC, Moseson DE, Richard CA, et al. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J Control Release. 2022;doi: 10.1016/j.jconrel.2021.12.038.
Chen, Y. C., Moseson, D. E., Richard, C. A., Swinney, M. R., Horava, S. D., Oucherif, K. A., Cox, A. L., Hawkins, E. D., Li, Y., DeNeve, D. F., Lomeo, J., Zhu, A., Lyle, L. T., Munson, E. J., Taylor, L. S., Park, K., & Yeo, Y. (2022). Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. Journal of controlled release : official journal of the Controlled Release Society, . https://doi.org/10.1016/j.jconrel.2021.12.038
Chen, Yun-Chu, et al. "Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam." Journal of controlled release : official journal of the Controlled Release Society vol. (2022). doi: https://doi.org/10.1016/j.jconrel.2021.12.038
Chen YC, Moseson DE, Richard CA, Swinney MR, Horava SD, Oucherif KA, Cox AL, Hawkins ED, Li Y, DeNeve DF, Lomeo J, Zhu A, Lyle LT, Munson EJ, Taylor LS, Park K, Yeo Y. Development of hot-melt extruded drug/polymer matrices for sustained delivery of meloxicam. J Control Release. 2022 Jan 03; doi: 10.1016/j.jconrel.2021.12.038. Epub 2022 Jan 03. PMID: 34990702.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 74 entries